Examples of using Hizentra in English and their translations into Polish
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
Hizentra was evaluated in 33 paediatric subjects(21 children[3 to 11 years]
Because the solution contains no preservative, Hizentra should be used/infused as soon as possible after opening the vial.
fever, photophobia, nausea, and vomiting after receiving Hizentra.
Hizentra may be injected into sites such as abdomen,
remains the only option, should be switched to Hizentra only under close medical supervision.
No serious bacterial infections were reported during the efficacy period in subjects receiving Hizentra during clinical studies.
Hizentra is used in patients whose blood does not contain enough antibodies(proteins that help the body to fight infections and other diseases), also known as immunoglobulins.
Hizentra is used to raise abnormally low immunoglobulin levels in your blood to normal levels replacement therapy.
Hizentra may impair the effect of some live virus vaccines such as measles,
Hizentra must not be used in patients with hyperprolinaemia a genetic disorder causing high levels of the amino acid proline in the blood.
If you think you should receive Hizentra more or less frequently,
Please also refer to section 2“What you need to know before you use Hizentra” for additional details on circumstances which increase the risk of side effect.
seen during Hizentra treatment compared with the lowest levels seen during previous immunoglobulin treatment.
What Hizentra is and what it is used for What Hizentra is.
It is strongly recommended that every time Hizentra is administered to a patient,
in accordance with current guidelines, Hizentra was investigated in one main study involving 51 PID patients who had already received human immunoglobulin treatment for at least six months.
The CHMP noted that Hizentra can prevent serious bacterial infections in PID patients through weekly injections which may be given at home,
may be obtained if Hizentra is administered subcutaneously every two weeks using double the weekly dose during maintenance therapy.
product are recorded in order to maintain a record of the batches used see section 3“How to use Hizentra”.
The patients received Hizentra every week for 28 weeks.